ECI (Enhanced Compliance Inc.), a leading provider of regulatory, quality, and engineering services for the life sciences industry, is pleased to announce its inclusion in the 2024 INC 5000 Fast Growing Companies list, with 203% growth over three years. This accolade highlights ECI’s rapid expansion, innovative solutions, and dedication to customer satisfaction. The INC 5000 list, curated by INC magazine, ranks America’s fastest-growing private companies based on three-year revenue growth, generating 874,940 jobs and $317 billion in revenue. ECI’s inclusion underscores its success in the life sciences consulting sector.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240816831291/en/
(Graphic: Business Wire)
“We are deeply honored by this recognition from Inc., which underscores our strong foundation, core values, and team’s continued dedication and excellence,” said Brijesh Patel, ECI’s newly appointed Chief Executive Officer. “Being included in the Inc. 5000 list is a testament to our unwavering commitment to advancing health outcomes through comprehensive, full-product life cycle consulting services for the life sciences sector. Our recent expansion with the ISO 17025-certified packaging testing laboratory in Costa Rica exemplifies our strategic focus on meeting critical industry demands, bolstering local expertise, and fostering sustainable growth.”
In the past year, ECI has achieved significant milestones, including:
ECI strategically rebranded Enhanced Compliance, Inc. and its subsidiary CRx Life Sciences, creating a unified entity with a refreshed brand identity focused on innovation and growth in the life sciences industry.
Brijesh Patel, co-founder, has been appointed as the new CEO. He succeeds Hoyt Randall Smith, who retired. Patel brings over 25 years of experience in the life sciences sector to his new leadership role.
ECI is expanding its influence in the life sciences by constructing an ISO 17025-certified packaging testing laboratory in Costa Rica. This represents a significant investment to enhance local technical services and support various industries in the LATAM region.
Enhanced Service offering by adding Audit, Regulatory Intelligence, Device Cybersecurity, and Training Practices.
Implemented ISO 9001 quality system Internally.
About ECI
Established in 2012, ECI (Enhanced Compliance Inc.) stands as a beacon of excellence in the life sciences consulting arena. With a dedicated team of industry professionals, ECI boasts a proven track record in full product life cycle consulting for medical devices, pharmaceutical, biotech, and related industries. Our consultants, with an average of 15 years of experience, form an extensive network of global consultants, providing top-tier quality, regulatory, program management, and engineering solutions. ECI’s comprehensive services and tailored solutions are designed to cater to the unique needs of the dynamic and competitive life sciences market. For more information, visit our website and explore how we’re shaping the future of the life sciences sector.
View source version on businesswire.com:https://www.businesswire.com/news/home/20240816831291/en/
CONTACT: Media:
Linda Healan, Clarity Quest
Linda@clarityqst.com
877-887-7611Catherine Stilphen, ECI Marketing
catherine.stilphen@eci-rx.com
678-698-5442
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: RESEARCH MEDICAL DEVICES CONSULTING PROFESSIONAL SERVICES BIOTECHNOLOGY HEALTH PHARMACEUTICAL OTHER SCIENCE SCIENCE
SOURCE: ECI
PUB: 08/16/2024 08:03 AM/DISC: 08/16/2024 08:03 AM
Get updates delivered to you daily. Free and customizable.
It’s essential to note our commitment to transparency:
Our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. As a platform hosting over 100,000 pieces of content published daily, we cannot pre-vet content, but we strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation.
Comments / 0